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1. Introduction
  Non-steroidal anti-inflammatory drugs (NSAIDs) are the 
centerpiece of pharmacotherapy for most rheumatological 
disorders, and are used in large numbers as analgesics 
and antipyretics, both as prescription drugs and over the 
counter purchases[1]. Diclofenac, a non-steroidal anti-
inflammatory drug, was developed in the late 1970s and 
was approved for clinical use in treating several rheumatic 
diseases, and as an analgesic and anti-inflammatory agent. 
Like other non-steroidal anti-inflammatory drugs, long 
term use of diclofenac has been associated with a small but 
significant incidence of hepatotoxicity, ranging from mild, 
asymptomatic, reversible increase in liver function tests to 
jaundice and hepatitis, including several reports of fatal 
hepatitis[2,3].
  Liver regulates various important metabolic functions. 
Hepatic damage is associated with distortion of these 
metabolic functions[4]. In the absence of reliable liver 
protective drugs in allopathic medical practices, herbs play 
a major and important role in the management of various 
liver disorders[5].
  Woodfordia fruticosa Kurz (syn. Woodfordia floribunda 
Salisb.) belongs to the family Lythraceae. Frequently 
used English names are Fire Flame Bush and Shiranjitea 
while in India (Gujarat) it is known as Dhavdi. All parts 
of this plant possess valuable medicinal properties viz. 
anti-inflammatory, anti-tumor, hepatoprotective and 
free radical scavenging activity[6,7], but flowers are in 
maximum demand[8]. In the present study, methanol extract 
of Woodfordia fruticosa Kurz. flowers was evaluated for 
its hepatoprotective property against diclofenac induced 
hepatotoxicity. 
2. Materials and methods
2.1. Plant material       
  The fresh flowers of Woodfordia fruticosa were collected 
from Junagadh (Girnar region), Gujarat, India in the month 
of March 2009. The plant was compared with voucher 
specimen (voucher specimen No. PSN303) deposited by 
Dr.  Nagar PS at Department of Biosciences, Saurashtra 
University, Rajkot, Gujarat, India. 
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2.2. Preparation of the extract
  The flowers were washed under tap water, air dried, 
homogenized to fine powder and stored in airtight bottles. 
Ten grams of dried powder was first defatted with petroleum 
ether and then extracted with methanol by using Soxhlet 
apparatus. The solvent was evaporated to dryness and the 
dried crude extract was stored in air tight bottle at 4 曟. The 
percentage yield of methanol extract was 36%. For testing, 
the Woodfordia fruticosa methanol (WFM) extract was 
dissolved in sterile distilled water and diluted to the desired 
concentrations. 
2.3. Chemicals 
  All chemicals were of analytical-reagent grade and 
obtained from the following sources: Diclofenac sodium 
from Lekar Pharma Ltd. (Panoli, Bharuch, India); Silymarin 
from Micro Labs Ltd. (Solan, HP, India); Petroleum 
ether, methanol, acetic acid, hydrochloric acid from 
Merck (Darmstadt, Germany); Biochemical kits from 
Span Diagnostics Ltd (Sachin, Surat, India); Dipotassium 
hydrogen phosphate, potassiun dihydrogen orthophosphate, 
potassium dichromate,  sodium citrate,  hydrogen 
peroxide (H2O2), trichloroacetic acid (TCA), 5,5-dithiobis 
(2-nitrobenzoic acid) (DTNB), sodium azide, glutathione 
reduced (GSH), tris free base were purchased from Himedia 
(Mumbai, India).
2.4. Animals 
  Wistar albino rats of either sex (180-220 g) were used for 
the study. The animals were obtained from Xcelris Labs 
Ltd., Ahmedabad. All the rats were kept in standard plastic 
rat cages with stainless steel coverlids and wheat straw 
was used as bedding material. The animals were kept at 
the animal house of Department of Biosciences, Saurashtra 
University, Rajkot. The animals were facilitated with 
standard environmental condition of photoperiod (12:12 h 
dark: light cycle) and temperature [(25依2)℃] They were 
provided with commercial rat and mice feed (Pranav Agro 
Industries Ltd., Amruth Brand rat & mice pellet feed) and 
water given ad libitum. The use of these animals and the 
study protocols were approved by CPCSEA recognized local 
ethical committee.
2.5. Hepatoprotective study
  The rats were divided into five groups with six rats in 
each. Group I (Control) served as normal and received the 
vehicle alone (Sterile distilled water 10 mL/kg body weight 
p.o.) for 5 days. Group II (Toxin control) animals received 
diclofenac (50 mg/kg i.p.) on the 3rd and 4th day. Group 
III (WFM-400) and IV (WFM-600) were treated with WFM at 
a dose level of 400 mg/kg and 600 mg/kg body weight p.o. 
per day, respectively for 5 days and on the 3rd and 4th day 
diclofenac (50 mg/kg i.p.) was given 1 h after the treatment 
of the extract. Group V (Standard) was treated with standard 
drug silymarin (100 mg/kg p.o.) for 5 days and on the 3rd 
and 4th day diclofenac (50 mg/kg i.p.) was given 1 h after the 
treatment of the drug. The animals were sacrificed 48 h after 
the last injection of diclofenac under mild ether anesthesia. 
The blood was collected and allowed to stand for 30 min at 
37 ℃ and then centrifuged to separate the serum.
  The liver was quickly removed and perfused immediately 
with ice-cold saline (0.9% NaCl). A portion of the liver 
was homogenized in chilled Tris-HCl buffer (0.025 M, 
pH 7.4) using a homogenizer. The homogenate obtained 
was centrifuged in a centrifuge at 5 000 rpm for 10 min, 
supernatant was collected and used for various antioxidant 
enzyme assays.
2.6. Estimation of biochemical parameters and antioxidant 
enzymes
The separated serum was estimated for various biochemical 
parameters like total protein, albumin, blood urea nitrogen, 
alanine aminotransferase (ALT), aspartate aminotransferase 
(AST), and alkaline phosphatase (ALP) levels. Glutathione 
peroxidase and catalase activities and content of total 
protein and glutathione[9] was determined in the liver 
homogenate. The absorbance of all the parameters was 
measured in a UV-VIS Spectrophotometer (Shimadzu, Tokyo, 
Japan). 
2.7. Histopathological study
  A portion of the liver was cut into approximately 6 mm 
size and fixed in phosphate buffered 10% formaldehyde 
solution. After embedding in paraffin wax, thin sections of 
5 毺m thickness of liver tissue were cut and stained with 
hematoxylin-eosin. The thin sections of liver were made 
into permanent slides and examined under Zeiss microscope 
with photographic facility and photomicrographs were taken.
2.8. Statistical analysis
  The data obtained from animal experiments are expressed 
as mean依SEM. Graphs were prepared using GraphPad Prism 
and data was subjected to analysis of variance (ANOVA) 
followed by Dunnett’s t-test. Values are considered 
statistically significant at P<0.05. 
3. Results
3.1. Serum biochemical analysis
  The results of serum biochemical parameters in pre-
treatment of WFM with respect to induction of hepatotoxicity 
using diclofenac sodium are shown in Figure 1. The level 
of total protein and albumin was depleted in the group 
treated with diclofenac sodium (toxin control) and they 
were significantly decreased (P<0.001) when compared 
with the normal control group. Serum ALT and AST levels 
were determined as an evaluation of hepatic function. The 
administration of diclofenac sodium markedly increased 
serum ALT and AST levels which were significant as 
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compared to normal control group (P<0.01, P<0.001, 
respectively). The ALP and blood urea nitrogen (BUN) levels 
also increased significantly (P< 0.001) in the group treated 
with diclofenac sodium.
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Figure 1.   Effect of WFM on different biochemical parameters in 
diclofenac induced hepatic damage in rats. 
Group I: Normal control, Group II: Toxin control diclofenac, Group 
III: WFM-400 mg/kg + diclofenac, Group IV: WFM-600 mg/kg + 
diclofenac, Group V: Silymarin-100 mg/kg + diclofenac. Results are 
expressed as mean 依 SEM (n = 6). #P < 0.05, ## P < 0.01, ### P < 0.001 
as compared with normal control group; * P < 0.05, ** P < 0.01, *** P < 0.001
as compared with toxin control group.
  The groups that received the pre-treatment of WFM at 
dose levels of 400 and 600 mg/kg body weight significantly 
controlled the change in the biochemical parameters. 
The extract at dose levels of 400 and 600 mg/kg exhibited 
significant increase (P<0.05, P<0.01, respectively) in the 
serum total protein level as compared to toxin control 
group. The albumin level in lower as well as higher dose 
group increased significantly (P<0.001) as compared to 
toxin control group and the effect was comparable with the 
standard group (P<0.001) treated with silymarin. In WFM-
600 group the level of ALT and AST significantly decreased 
(P<0.05), the result was comparable to the standard group. 
The ALP level significantly decreased in lower as well 
higher dose treated animals (P<0.001). The BUN level also 
decreased in both the dose groups significantly (P<0.01) as 
compared to toxin control group. 
3.2. Liver antioxidants
  The results of relative liver weight, liver total protein, GSH 
and antioxidant enzymes in diclofenac sodium induced 
hepatotoxicity are given in Figure 2. The relative liver weight 
in toxin control group increased significantly (P<0.001) as 
compared to normal control group. The total protein and GSH 
levels from the liver homogenate decreased significantly 
(P<0.001, P<0.05, respectively) in toxin control group. The 
catalase (CAT) and glutathione peroxidase (GPx) activity in 
the toxin control group was also found significantly (P<0.001, 
P<0.05, respectively) depleted as compared to the normal 
control group. The  mean relative liver weight decreased 
significantly in WFM-400 and WFM-600 (P<0.001) treated 
group as compared to the toxin control group. The result of 
the higher dose group was comparable to the standard drug 
treated group (P<0.001). The total protein and GSH levels 
from liver homogenate in WFM treated groups elevated, but 
total protein level was not significant. However, pretreatment 
with WFM significantly recovered the diclofenac sodium 
induced GSH depletion in lower (P<0.01) and higher dose 
group. The catalase and GPx activity increased at both the 
dose levels. At higher dose WFM exhibited good activity 
(P<0.01, P<0.05, respectively). GPx activity of WFM-600 
group was similar to that of standard drug treated group. 
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Figure 2. Effect of WFM on relative liver weight and different liver 
antioxidant enzymes in diclofenac induced hepatic damage in rats. 
Group I: Normal control, Group II: Toxin control diclofenac, Group 
III: WFM-400 mg/kg + diclofenac, Group IV: WFM-600 mg/kg + 
diclofenac, Group V: Silymarin-100 mg/kg + diclofenac. Results are 
expressed as mean 依 SEM (n = 6). # P<0.05, ## P<0.01, ### P<0.001 as 
compared with normal control group; * P<0.05, ** P<0.01, *** P <0.001 
as compared with toxin control group.
3.3. Histopathological changes
  In normal control animal liver histological sections showed 
that hepatocytes were well-preserved, uniform cytoplasm 
and sinusoidal spaces (Figure 3A). Compared with the 
normal control group, liver tissue in the rats treated with 
diclofenac revealed extensive liver injuries, characterized by 
severe hepatocellular degeneration, necrosis, inflammatory 
cell infiltration, sinusoidal dilatation and cytoplasmic 
vacuolation (Figure 3B). However, the histopathological 
hepatic lesions induced by administration of diclofenac was 
remarkably improved by the treatment with WFM (Figure 3C 
& 3D), and showed marked protective effect by decreasing 
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hepatocellular degeneration and necrosis. The protective 
effect was also observed in silymarin treated animals (Figure 
3E). This was in good agreement with the results of serum 




Figure 3. Photographs of liver sections of diclofenac treated rats 
(hematoxylin and eosin stained, 10伊). 
(A) Normal control group, (B) Toxin control (diclofenac) group, (C) 
WFM-400 mg/kg + diclofenac, (D) WFM-600 mg/kg + diclofenac, 
(E) Silymarin-100 mg/kg + diclofenac. 
4. Discussion 
  Hepatic fibrosis is usually initiated by hepatocyte 
damage. Biologic factors such as hepatitis virus, bile duct 
obstruction, cholesterol overload, etc. or chemical factors 
such as CCl4 administration, alcohol intake are known to 
contribute to liver fibrosis. The incidence of chronic fibrosis 
is high, but there have been no satisfactory agents with 
ascertained effectiveness and few side effects to liver. So, 
finding effective ways to inhibit liver fibrosis and prevent 
the development of cirrhosis are of great significance[10]. The 
ability of a hepatoprotective drug to reduce the injurious 
effects or to preserve the normal hepatic physiological 
mechanisms which have been disturbed by a hepatotoxic 
agent is the index of its protective effect[11].
  Hepatotoxicity is currently a class warning for NSAIDs 
and infrequent hepatic injury has been observed for nearly 
all NSAIDs currently on the market, there are 3 drugs that 
have more commonly been associated with liver disease: 
diclofenac, sulindac, and aspirin[12]. Diclofenac sodium, 
undergoes similar hepatic metabolism both in rat and in 
humans. Major metabolic pathways are the hydroxylation in 
position 4 and 5 and to a much lesser extent the formation of 
3ʹ-hydroxy- (humans) and 4ʹ,5-dihydroxydiclofenac (rat and 
humans). Diclofenac and its metabolites undergo extensive 
conjugation with glucuronic acid and sulfate. The major 
constitutive P450 form involved in diclofenac hydroxylation 
in man is cytochrome P4502C9, the human orthologous form 
of rat 2C11. Diclofenac forms selective protein adducts in 
livers of treated mice[13]. This is caused by a transacylation 
reaction of its glucuronide conjugate. This mechanism has 
been proposed to explain both the allergic and intrinsic 
hepatotoxicity of the drug.
  Since unwanted side effects of diclofenac in man and 
other mammals were reported to occur particularly in the 
liver[14] it was thought of interest to evaluate WFM for their 
hepatoprotetive property in diclofenac induced hepatic 
damage in rats. In the present study, the administration of 
diclofenac to rats decreased the total protein and albumin 
level and increased the BUN level significantly. The 
pretreatment of WFM at two different dose levels restored the 
level of protein, albumin and BUN towards normalization. 
Hepatocellular injury from metabolic inhibition, oxygen 
radical toxicity, immunologically mediated damage, or some 
other mechanism results in predominant aminotransferase 
elevation, with elevations of alkaline phosphatase[15]. The 
ALT, AST and ALP levels significantly elevated when rats 
were administered with diclofenac indicating hepatocellular 
damage. The increased levels of these enzymes were 
significantly decreased by pretreatment with WFM in dose 
dependent manner. This is the indication of stabilization 
of plasma membrane as well as repair of hepatic tissue 
damages caused by diclofenac sodium. The hepatoprotetive 
property of Polyalthia longifolia in diclofenac induced 
hepatic damage in rats was reported by Tanna et al[16].
  The significant increased liver weight of diclofenac 
exposed animals seems to be due to toxic potential of 
diclofenac. The significant increase in weight of liver was, 
however, found to be associated with concomitant increase 
of serum AST and ALT enzyme levels. It is important to note 
that the elevated activity of serum AST and ALT recorded 
in this study may be due to loss of enzymes of liver tissue. 
Pretreatment of WFM decreased the liver weight significantly 
indicating recovery of liver tissue from damage. Significant 
decrease in total protein of the liver contents is a reflection 
of hepatic toxicity[17,18]. The significant reductions of 
protein in diclofenac intoxicated group indicate depletion 
in the protein reserve and thus suggest hepatic toxicity. 
WFM administration increased the total protein leading to 
normalization. GSH is an extremely efficient intracellular 
buffer for oxidative stress and GSH acts as a non-enzymatic 
antioxidant that reduces H2O2, hydroperoxides (ROOH) and 
xenobiotic toxicity[19-24]. The level of GSH depleted when 
animals were injected with diclofenac. The depleted level 
of GSH raised with the pretreatment of WFM. The catalase 
and GPx are enzymatic antioxidants widely distributed 
in all animal tissues that decomposes hydrogen peroxide 
and protects the tissue from highly reactive hydroxyl 
radicals. Therefore, the reduction in the activity of these two 
enzymes may result in a number of deleterious effects due 
to the accumulation of superoxide radicals and hydrogen 
peroxide. In the present study, WFM significantly restored 
the hepatic catalase and GPx activity, which indicated that 
WFM could scavenge reactive free radicals that eventually 
lessen the oxidative damage to the tissues and subsequently 
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improved the activities of these antioxidant enzymes. 
The preventive effect of WFM was also confirmed by the 
results of histopathological examination, as evidenced by 
a dose related decrease in the incidence and severity of 
histopathological hepatic lesions.
  WFM pretreatment prevented the reduction in the 
antioxidant enzyme activities and consequent oxidative 
damage to the liver. In fact, the multiple dose pretreatment 
of WFM alone significantly boosted the antioxidant enzyme 
activities. Similar results were also reported by Molina et 
al[25] and Scharf et al[26]. In conclusion, the results of this 
study demonstrate that the WFM was effective in prevention 
of diclofenac induced hepatic damage in rats. However, 
the hepatoprotective mechanisms of these medicinal herb 
constituents remain to be elucidated.
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